Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase

Rackham, M. D., Yu, Z., Brannigan, J. A., Heal, W. P., Paape, D. , Barker, K. V., Wilkinson, A. J., Smith, D. F., Leatherbarrow, R. J. and Tate, E. W. (2015) Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase. MedChemComm, 6(10), pp. 1761-1766. (doi: 10.1039/C5MD00241A)

Full text not currently available from Enlighten.

Abstract

N-Myristoyltransferase (NMT) is a potential drug target in Leishmania parasites. Scaffold-hopping from published inhibitors yielded the serendipitous discovery of a chemotype selective for Leishmania donovani NMT; development led to high affinity inhibitors with excellent ligand efficiency. The binding mode was characterised by crystallography and provides a structural rationale for selectivity.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Paape, Dr Daniel
Authors: Rackham, M. D., Yu, Z., Brannigan, J. A., Heal, W. P., Paape, D., Barker, K. V., Wilkinson, A. J., Smith, D. F., Leatherbarrow, R. J., and Tate, E. W.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:MedChemComm
Publisher:Royal Society of Chemistry
ISSN:2040-2503
ISSN (Online):2040-2511

University Staff: Request a correction | Enlighten Editors: Update this record